ACTH following overnight dexamethasone suppression can be used in the verification of autonomous cortisol secretion in patients with adrenal incidentalomas
Clinical Endocrinology Jan 28, 2021
Puvaneswaralingam S, Kjellbom A, Lindgren O, et al. - Given the significance of accurately diagnosing autonomous cortisol secretion (ACS) during the investigation of adrenal incidentalomas, but a low specificity of cortisol ≥ 50 nmol/L after overnight dexamethasone suppression (cortisolONDST), researchers sought to examine if ACTH following overnight dexamethasone suppression (ACTHONDST) and cortisol following a 2‐day dexamethasone suppression test (cortisol2‐DAYDST) can aid in determining HPA axis suppression during ONDST. They conducted a cross‐sectional study including patients with adrenal incidentalomas and basal ACTH ≥ 2.0 pmol/L who underwent ONDST. Findings suggest the utility of ACTHONDST and ACTHONDST/ACTH ratio (ACTH ratio) as markers of HPA axis suppression in the evaluation of adrenal incidentalomas. They suggest that ACS should be suspected in cases with cortisolONDST ≥ 50 nmol/L with ACTHONDST < 0.6 pmol/L or ACTH ratio < 18%.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries